Connect with us

Artificial Intelligence

Neko Health raises $700 million to bring AI-powered full-body scans to the US

Published

on

AI body scans

A $700 million bet on preventive health

Neko Health, the Swedish health-tech startup co-founded by Spotify founder Daniel Ek, just closed a massive $700 million Series C funding round. The money will fuel the company’s expansion into the United States, starting with a flagship clinic in New York City.

The round was led by Lightspeed Venture Partners and O.G. Venture Partners. Existing backers Atomico, General Catalyst, and Lakestar also participated, alongside new investors including Liberty City Ventures, Positive Sum, and BDT & MSD. David Ofer of O.G. Venture Partners is set to join Neko’s board, pending regulatory approval.

With this latest injection, Neko’s total disclosed funding since 2023 now exceeds $1 billion. The company previously raised $65 million in a Series A in 2023 and another $260 million in January 2025.

A notable detail: the investor list includes Meta CEO Mark Zuckerberg and his wife Priscilla Chan, tennis legend Maria Sharapova, musician will.i.am, and former footballer Thierry Henry. Earlier individual investors include Reddit co-founder Alexis Ohanian and actor Zoë Saldaña.

What happens inside a Neko Health scan?

Neko’s clinics offer a 60-minute, non-invasive, radiation-free health assessment. The service combines full-body imaging, blood tests, custom-built sensors, and artificial intelligence — all reviewed by a clinician during the same visit.

The scan includes an electrocardiogram, arterial measurements, body-composition analysis, and more than 2,000 high-resolution images that map a customer’s skin. Blood samples are processed on-site, so results are ready before the patient leaves. A doctor or nurse discusses findings in person.

The company screens for potential signs of skin cancer, cardiovascular disease, diabetes, metabolic syndrome, and stroke risk factors. Many of these measurements — blood pressure, cholesterol, blood glucose — are available through standard healthcare. Neko’s pitch is convenience: one appointment, proprietary imaging, automated data collection, and immediate results.

But the company’s public materials don’t include a comparative study showing whether this bundled approach actually improves clinical outcomes or saves money versus established preventive care pathways.

US expansion: New York first, more cities to come

Neko plans to open clinics in New York and other US cities, though it hasn’t named specific additional locations or provided a detailed timeline. A waitlist for the New York clinic is already live on its website. Pricing for US scans hasn’t been announced.

Currently, the company operates eight clinics across the UK and Sweden: two in Stockholm, one each in Manchester and Birmingham, and four in London (Marylebone, Spitalfields, Covent Garden, and Victoria). In the UK, a scan costs £299 (about $400); in Sweden, it’s 2,750 Swedish kronor (roughly $285).

Since launching in 2023, Neko says it has completed 100,000 scans. More than 350,000 people have registered or joined waitlists. The company reports that 75% of customers book and prepay for a second scan at the end of their first appointment — a strong retention signal.

That repeat-booking model lets clinicians compare measurements and skin images over time. But public information doesn’t establish whether annual screening is the right interval for every age or risk group.

Regulatory clearance and the US healthcare puzzle

Two of Neko’s internally developed devices have received FDA 510(k) clearance — Derma-2 as an adjunctive telethermographic system, and Spectrum-2 as a tissue-saturation oximeter for cardiovascular measurements. These clearances apply to the specific devices and their intended uses, not to the complete Neko Health Scan as a single FDA-approved screening service.

The company positions its US clinics as preventive health and wellness providers, not full-service medical practices. Its privacy notice explicitly advises customers to continue seeing their existing doctors for diagnoses and treatment, including for conditions flagged during a Neko scan.

Specialist clinicians — dermatologists and cardiologists — review findings that need further examination. Follow-up appointments, referral letters, and introductions to outside specialists are included when recommended. But Neko’s US clinics don’t currently participate in health insurance plans, and the company says most services aren’t covered by a payer. Customers will pay out of pocket for the initial assessment.

Neko hasn’t disclosed what customers might pay for diagnostic tests or treatment delivered by external providers, nor whether employers or insurers will subsidize access.

What about the evidence?

Publicly available information doesn’t include a completed peer-reviewed study validating the full screening service. A trial registered on ClinicalTrials.gov is evaluating Neko’s multimodal skin-imaging technology for screening and diagnostic-support applications, including skin cancer and Raynaud’s phenomenon. But that trial is still ongoing.

Neko’s materials don’t disclose how often its scans produce false-positive findings, how many customers undergo additional procedures, or how many flagged abnormalities turn out to be clinically unimportant. The FDA clearances for individual devices don’t establish the performance of every algorithm used to combine or interpret the resulting data.

The company did share health-outcome data from 1,469 customers who completed a second scan about a year after their first. The group recorded improvements in blood pressure, cholesterol, and blood sugar, while body weight stayed broadly stable. But Neko itself says this wasn’t a scientific study — there was no control group. Customers could have started treatment or changed their behavior between appointments, so the figures don’t prove the scans caused the improvements.

CEO Hjalmar Nilsonne said part of the new capital will fund further research and development. Neko recently added body-composition measurements and clinician reviews of wearable-device data. It also introduced updated versions of its Derma, Echo, and Spectrum medical devices, which capture more health data and automate more of the scanning process.

Neko didn’t disclose its valuation after this round. The Financial Times, citing unnamed sources, pegged it at around $7 billion.

For a deeper look at how AI is reshaping diagnostics, check out our coverage of NHS AI blood test reducing invasive womb cancer checks. And if you’re interested in the broader trend of preventive health screening technology, we’ve got you covered.

Continue Reading

Artificial Intelligence

XDOF, three months out of stealth, is already closing in on a $1.2B Series B

Published

on

XDOF Series B

From stealth to unicorn talk in record time

Three months. That’s how long XDOF has been out in the open. And already, the robotics data startup is in late-stage conversations to raise a Series B at a valuation hovering around $1.2 billion, according to multiple sources familiar with the negotiations. The round would be led by 8VC.

Not bad for a company that didn’t even exist publicly until June.

XDOF was co-founded in 2024 by UC Berkeley researchers Philipp Wu (CEO) and Fred Shentu (CTO). Their origin story traces back to a research project called GELLO — a low-cost teleoperation system that lets a human operator control a robotic arm from a distance. The goal? Generate training data for robots. That work produced an influential paper in robotics and, eventually, a company.

The startup’s Series A, a $70 million round announced in June, drew participation from Thrive Capital, Andreessen Horowitz, Lux, and Spark Capital. At the time, XDOF wasn’t planning to raise again so soon. But the market had other ideas.

Why investors are knocking on XDOF’s door

The reason for the sudden interest? Growth. Real, measurable growth.

XDOF’s annualized revenue is approaching $50 million, sources say. That kind of traction, so soon after a Series A, tends to make venture capitalists sit up and take notice. It also tends to make them pick up the phone.

“They weren’t out raising,” one person familiar with the situation told TechCrunch. “The VCs came to them.”

Terms aren’t final, and the total capital being raised remains unclear. TechCrunch couldn’t confirm whether the $1.2 billion valuation includes the new funding or sits on top of it. Both XDOF and 8VC declined to comment.

The Scale AI for physical robots

XDOF’s pitch is straightforward: it builds the data pipelines, collection tools, and annotation systems that frontier AI labs and robotics companies would rather not build themselves. Think of it as an outsourced data-supply chain for the robotics industry.

Investors describe XDOF as the Scale AI or Mercor of physical robotics — a nod to the data-labeling giants that powered the AI boom. The comparison makes sense. Large language models trained on the entire internet. Physical robots? They don’t have that luxury. There’s no massive, ready-made dataset of real-world robot interactions sitting online. That scarcity makes data collection the critical bottleneck on the road to general-purpose machines.

Wu felt that bottleneck firsthand as a PhD student. His research on how robots learn from large datasets kept hitting the same wall: “large-scale data to work with” simply didn’t exist, he told TechCrunch in June.

Building the ABC dataset

XDOF is tackling that problem head-on. The startup is partnering with UC Berkeley’s AI Research lab to release what it believes is the largest collection of high-quality robot training data ever assembled. The dataset is called ABC.

Collecting that data requires a hybrid approach. XDOF combines remote robot teleoperation with human collectors who wear sensors to record everyday tasks. Think folding clothes. Flattening boxes. The mundane, physical chores that robots still struggle to master.

The company plans to hire and train teams of data collectors around the world. Two main roles are emerging:

  • Teleoperators who steer robots remotely to demonstrate tasks
  • Egocentric operators who wear body sensors to capture natural movement data

Early traction and the competitive landscape

XDOF has already signed up 20 customers, including several frontier AI labs, according to previous statements to TechCrunch. That customer base, combined with the revenue trajectory, helps explain the valuation chatter.

But XDOF isn’t alone in this niche. Other startups chasing real-world data for robot training include Mecka AI. And the human-data platforms that started with LLMs — like Scale AI and Micro1 — are expanding beyond text and images into physical domains.

The race to build the data infrastructure for physical AI is heating up. Whoever wins it will effectively control the fuel supply for the next generation of robots. That’s a position worth paying up for.

Whether the $1.2 billion valuation holds remains to be seen. Deals at this stage can shift. But the fact that XDOF is even in this conversation — three months after emerging from stealth — says something about the demand for what it’s building.

For more on how data is shaping the future of AI, check out AI data labeling trends and robotics funding rounds in 2024.

Continue Reading

Artificial Intelligence

New York City Pulls AI From Younger Classrooms—Here’s Why It Matters

Published

on

NYC AI ban

New York City Just Hit Pause on AI in Classrooms

New York City Public Schools is drawing a hard line: no generative AI for students from 2-K through eighth grade during the 2026-2027 school year. That’s over half a million kids walking into classrooms next week without access to AI-powered tools.

The district says it will remove software with student-facing AI features and block AI companion chatbots. High schoolers? They’re exempt. This isn’t a blanket ban—it’s a targeted move to decide when kids should actually start using the technology.

Mayor Zohran Mamdani put it bluntly: “The tech industry wants us to believe that AI-powered early education is not only inevitable, but necessary. We do not see it that way.”

Why NYC Is Worried About AI for Younger Students

The fear isn’t just that a kid will ask ChatGPT to write an essay. City officials want younger students to build core skills—critical thinking, creativity, communication—without leaning on AI as a crutch. They’re also pushing for stronger human connections in classrooms, not another screen.

Schools Chancellor Kamar Samuels said the city refuses to assume that innovation automatically equals more technology in front of students. It’s a deliberate slowdown, and it follows last year’s bell-to-bell cellphone ban that already limits device use during school hours.

What Happens When Kids Reach High School?

AI doesn’t vanish once students hit ninth grade. Instead, the district plans to roll out AI literacy classes twice a year. The goal? Teach teenagers how to think critically about the technology before they become dependent on it.

That’s a different approach from just saying no. It’s about timing—letting younger minds develop without AI, then giving older students the tools to question it.

The National Battle Over AI in Education

NYC’s decision sits at the center of a much bigger fight. The White House has pushed educators to embrace AI responsibly. Some teachers already use it to craft lesson plans, give feedback, or break down tough subjects. But not everyone’s on board.

The Department of Health and Human Services recently gathered childhood experts to talk about excessive screen time. Officials have also called for tougher safeguards around social media and AI. The message? Kids are spending too much time in front of screens, and AI might make it worse.

A Bold Experiment With Zero AI

Here’s what makes NYC’s move so interesting: instead of asking how much AI younger students should use, the largest school district in the country is starting with none. For one academic year, they’re testing whether classrooms are better off with AI kept outside the door.

That’s a radical stance, and it’s not without critics. Some educators argue AI can personalize learning or help struggling students catch up. But NYC is betting that a year without AI will reveal what kids actually need—not what tech companies think they need.

What This Means for Parents and Teachers

If you’re a parent in NYC, expect changes. AI-based apps may disappear from your child’s school day. Teachers will need to plan lessons without generative AI tools. And students in grades 2-K through 8 will rely more on traditional methods—paper, pencils, and human interaction.

For teachers elsewhere, this could be a signal. NYC is the biggest district to take this stance, and its findings could shape policies nationwide. The next year will be watched closely by educators, policymakers, and tech giants alike.

What Happens Next?

The district will spend the year studying how generative AI affects students before deciding what comes next. That research could lead to a permanent ban, a partial rollout, or something entirely different.

For now, NYC is making a statement: childhood shouldn’t be an AI beta test. Whether that’s the right call or a step backward, we’ll know more in 2027. Until then, the debate over AI in schools just got a lot more interesting.

If you’re curious about how AI is shaping other areas, check out our take on AI in education trends or classroom technology policies.

Continue Reading

Artificial Intelligence

Meta’s Muse Spark 1.3 takes on GPT-5.6 and Claude — but can it really win?

Published

on

Muse Spark 1.3

Meta just fired a serious shot in the AI arms race

The company quietly unleashed Muse Spark 1.3, its most advanced AI model to date, and it’s aiming straight at the top dogs. Developers can already access and pay for the update, which Meta says represents a massive leap forward in performance.

It won’t stay confined to the developer sandbox for long. Over the coming weeks, the model will roll out across Instagram, Facebook, and the Meta AI assistant — putting it in front of billions of everyday users.

What makes Muse Spark 1.3 actually different?

Meta’s Chief AI Officer, Alexandr Wang, didn’t mince words. He called this “the biggest jump so far on model performance,” pointing to serious gains in two areas: coding and agentic tasks — the kind where the AI acts on your behalf rather than just answering questions.

But here’s the catch. Wang told Bloomberg that Muse Spark 1.3 is competitive with Anthropic’s Claude Fable 5.1 and even beats OpenAI’s GPT-5.6 Sol at coding. That’s a bold claim, especially with OpenAI’s upcoming Astra model lurking in the wings.

Take those comparisons with a grain of salt, though. Benchmarks can be gamed, and a model that crushes one test might stumble on a totally different task. Real-world performance is what actually matters.

Efficiency gains under the hood

Wang broke down a few upgrades that set Muse Spark 1.3 apart:

  • 25% fewer tokens needed to complete the same job — meaning lower costs and faster responses
  • Multi-workflow handling — it can juggle several tasks at once instead of forcing separate sessions
  • Better context retention across long, complicated instructions
  • Self-awareness of limits — the model now pauses to ask for clarification before taking any irreversible action

That last point is quietly important. AI that knows when it doesn’t know is a big step toward trustworthiness, especially for agentic use cases.

Pricing stays flat, adoption explodes

Here’s something developers will appreciate: Meta isn’t raising prices. Muse Spark 1.3 costs the same as its predecessor, Muse Spark 1.2. That’s a smart move when rivals are hiking rates.

Wang told Bloomberg that adoption on Meta’s developer platform has been strong — some users are burning through trillions of tokens every week. Those numbers suggest real usage, not just hype.

What about open-source fans? Meta hasn’t decided whether it will release the model’s weights — the blueprint that lets outside developers build on top of it. The older Muse Spark 1.2 weights are still headed for release, but the new model’s future remains unclear.

The bigger picture: Meta’s spending spree continues

Meta is still pouring billions into AI infrastructure, and Muse Spark 1.3 is the clearest signal yet that the company believes it’s closing the gap with OpenAI and Anthropic. Whether that’s true or just corporate bravado will play out in the benchmarks and real-world deployments over the coming months.

For now, the model is available to developers, and the app rollout is imminent. If you’re building on Meta AI tools, this update is worth a serious look. And if you’re just a curious user, you’ll likely meet Muse Spark 1.3 in your Instagram feed sooner than you think.

One thing’s certain: the AI race just got a lot more interesting.

Continue Reading

Trending